Julian Harrison
Stock Analyst at BTIG
(4.50)
# 279
Out of 5,124 analysts
73
Total ratings
57.58%
Success rate
21.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Julian Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MREO Mereo BioPharma Group | Maintains: Buy | $6 → $1 | $0.42 | +139.98% | 2 | Dec 29, 2025 | |
| LQDA Liquidia | Reiterates: Buy | $49 | $34.49 | +42.07% | 5 | Dec 26, 2025 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $100 → $118 | $42.28 | +179.09% | 2 | Dec 16, 2025 | |
| AKBA Akebia Therapeutics | Reiterates: Buy | $5 | $1.61 | +210.56% | 3 | Dec 2, 2025 | |
| TBPH Theravance Biopharma | Maintains: Buy | $25 → $40 | $18.71 | +113.79% | 3 | Nov 26, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $32 → $38 | $10.35 | +267.15% | 2 | Nov 24, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $17 | $2.36 | +620.34% | 4 | Nov 20, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $42 → $44 | $7.21 | +510.26% | 2 | Nov 14, 2025 | |
| ORKA Oruka Therapeutics | Maintains: Buy | $56 → $63 | $30.31 | +107.85% | 3 | Nov 13, 2025 | |
| CNTB Connect Biopharma Holdings | Reiterates: Buy | $10 | $2.82 | +254.61% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $61 | $31.12 | +96.02% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $82 | $87.34 | -6.11% | 3 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.00 | +100.00% | 3 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $15 | $4.30 | +248.84% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $115 | $75.48 | +52.36% | 2 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $15.43 | +81.46% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $120 | $134.86 | -11.02% | 3 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $85 | $13.18 | +544.92% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $18.16 | +120.26% | 2 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $32.76 | +113.68% | 3 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $37 | $41.43 | -10.69% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $20.36 | - | 3 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $48.48 | - | 2 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $9 | $1.58 | +469.62% | 5 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $3.01 | +165.78% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.58 | +1,279.07% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $150 | $0.59 | +25,497.27% | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $487.25 | - | 2 | Feb 11, 2022 |
Mereo BioPharma Group
Dec 29, 2025
Maintains: Buy
Price Target: $6 → $1
Current: $0.42
Upside: +139.98%
Liquidia
Dec 26, 2025
Reiterates: Buy
Price Target: $49
Current: $34.49
Upside: +42.07%
Nektar Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $100 → $118
Current: $42.28
Upside: +179.09%
Akebia Therapeutics
Dec 2, 2025
Reiterates: Buy
Price Target: $5
Current: $1.61
Upside: +210.56%
Theravance Biopharma
Nov 26, 2025
Maintains: Buy
Price Target: $25 → $40
Current: $18.71
Upside: +113.79%
Cullinan Therapeutics
Nov 24, 2025
Maintains: Buy
Price Target: $32 → $38
Current: $10.35
Upside: +267.15%
Rezolute
Nov 20, 2025
Reiterates: Buy
Price Target: $17
Current: $2.36
Upside: +620.34%
Cartesian Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $42 → $44
Current: $7.21
Upside: +510.26%
Oruka Therapeutics
Nov 13, 2025
Maintains: Buy
Price Target: $56 → $63
Current: $30.31
Upside: +107.85%
Connect Biopharma Holdings
Nov 13, 2025
Reiterates: Buy
Price Target: $10
Current: $2.82
Upside: +254.61%
Nov 4, 2025
Reiterates: Buy
Price Target: $61
Current: $31.12
Upside: +96.02%
Oct 28, 2025
Reiterates: Buy
Price Target: $82
Current: $87.34
Upside: -6.11%
Oct 16, 2025
Reiterates: Buy
Price Target: $8
Current: $4.00
Upside: +100.00%
Oct 13, 2025
Maintains: Buy
Price Target: $55 → $15
Current: $4.30
Upside: +248.84%
Oct 9, 2025
Reiterates: Buy
Price Target: $115
Current: $75.48
Upside: +52.36%
Oct 9, 2025
Initiates: Buy
Price Target: $28
Current: $15.43
Upside: +81.46%
Oct 7, 2025
Maintains: Buy
Price Target: $112 → $120
Current: $134.86
Upside: -11.02%
Sep 29, 2025
Downgrades: Neutral
Price Target: $85
Current: $13.18
Upside: +544.92%
Sep 29, 2025
Reiterates: Buy
Price Target: $40
Current: $18.16
Upside: +120.26%
Sep 16, 2025
Reiterates: Buy
Price Target: $70
Current: $32.76
Upside: +113.68%
Sep 12, 2025
Maintains: Buy
Price Target: $30 → $37
Current: $41.43
Upside: -10.69%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $20.36
Upside: -
Dec 2, 2024
Downgrades: Neutral
Price Target: n/a
Current: $48.48
Upside: -
Nov 29, 2024
Maintains: Buy
Price Target: $50 → $9
Current: $1.58
Upside: +469.62%
Nov 19, 2024
Upgrades: Buy
Price Target: $8
Current: $3.01
Upside: +165.78%
Nov 18, 2024
Initiates: Buy
Price Target: $8
Current: $0.58
Upside: +1,279.07%
Oct 11, 2023
Reinstates: Buy
Price Target: $150
Current: $0.59
Upside: +25,497.27%
Feb 11, 2022
Initiates: Neutral
Price Target: n/a
Current: $487.25
Upside: -